< Back to previous page
Researcher
Mustafa Varcin
- Keywords:Pharmacy and pharmacology
Affiliations
- Experimental Pharmacology (Research group)
Member
From2 Feb 2017 → 18 Mar 2019 - Pharmaceutical Chemistry, Drug Analysis and Drug Information (Department)
Member
From1 Oct 2008 → 30 Sep 2012
Projects
1 - 1 of 1
- Neuro-TARGET : integrated platform for target identification, validation and drug discovery with applications for neurodegenerative diseases.From1 Jan 2009 → 31 Dec 2012Funding: SBO (Strategic basic research)
Publications
1 - 8 of 8
- Involvement of CRH Receptors in the Neuroprotective Action of R-Apomorphine in the Striatal 6-OHDA Rat Model(2013)
Authors: Mustafa Varcin, Eduard Mihai Bentea, Steven Roosens, Sophie Sarre
Pages: 299-318 - Oxidative stress in genetic mouse models of Parkinson’s disease(2012)
Authors: Mustafa Varcin, Eduard Mihai Bentea, Sophie Sarre
- Acute versus long-term effects of 6-hydroxydopamine on oxidative stress and dopamine depletion in the striatum of mice(2011)
Authors: Mustafa Varcin, Eduard Mihai Bentea, Chris Van Den Haute, Veerle Baekelandt, Sophie Sarre
Pages: 128-136 - The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death(2011)
Authors: Mustafa Varcin, Sophie Sarre
Pages: 1141-1148 - Glutamate – dopamine interactions in the subthalamic nucleus. (Oral)(2010)Series: Monitoring Molecules in Neuroscience
Authors: Sophie Sarre, Ben Ampe, Anissa El Arfani, Mustafa Varcin
Pages: 75-77Number of pages: 3 - Susceptibility of PINK-1 deficient mice to 6-OHDA induced oxidative stress determined
with in vivo salicylate trapping(2010)Series: Monitoring Molecules in Neuroscience
Authors: Mustafa Varcin, Bavo Heeman, Chris Van Den Haute, Veerle Baekelandt, Sophie Sarre
Pages: 476-478Number of pages: 3 - In vivo study of the neuroprotective effects of candesartan against 6-hydroxydopamine induced neurotoxicity(2008)
Authors: Mustafa Varcin, Sophie Sarre
Pages: 78 - In vivo neurochemical and neuroprotective effects of candesartan in the 6-hydroxydopamine rat model of Parkinson's disease(2008)
Authors: Mustafa Varcin, Sophie Sarre
Pages: 3